Hepatic gene expression and lipid parameters in complement C3-/- mice that do not develop ethanol-induced steatosis

Journal of Hepatology

Volumn 46, Issue 5, 2007, Pages 907-914

  Bykov, Igor ^a   Jauhiainen, Matti ^b   Olkkonen, Vesa M ^b   Saarikoski, Sirkku T ^a   Ehnholm, Christian ^b   Junnikkala, Sami ^c   Väkevä, Antti ^c   Lindros, Kai O ^a   Meri, Seppo ^c  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Molecular Medicine   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Alcoholic liver steatosis; Alternative complement pathway; C3 deficiency; Hepatic gene expression; Lipoproteins; Mouse microarray

Indexed keywords

ADIPONECTIN RECEPTOR 2; ADIPOPHILIN; ALCOHOL; CHOLESTEROL; FATTY ACID BINDING PROTEIN; LIPID; PHOSPHOLIPASE D1; PHOSPHOLIPID TRANSFER PROTEIN;

ALCOHOLIC FATTY LIVER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; DOWN REGULATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GENE EXPRESSION; GENOTYPE; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; MALE; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADIPONECTIN; ANIMALS; BIOSYNTHETIC PATHWAYS; COMPLEMENT C3; DIETARY FATS; ETHANOL; FATTY LIVER, ALCOHOLIC; GENE EXPRESSION; INTERLEUKIN-10; LIPID METABOLISM; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34047131669     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.11.020     Document Type: Article

References (38)

1. Lieber C.S. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 34 (2004) 9-19
2. Nielsen C.H., Fischer E.M., and Leslie R.G. The role of complement in the acquired immune response. Immunology 100 (2000) 4-12
3. Ogden C.A., and Elkon K.B. Role of complement and other innate immune mechanisms in the removal of apoptotic cells. Curr Dir Autoimmun 9 (2006) 120-142
4. Oksjoki R., Kovanen P.T., and Pentikainen M.O. Role of complement activation in atherosclerosis. Curr Opin Lipidol 14 (2003) 477-482
5. Cianflone K., Xia Z., and Chen L.Y. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta 1609 (2003) 127-143
6. Baldo A., Sniderman A.D., St-Luce S., Avramoglu R.K., Maslowska M., Hoang B., et al. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 92 (1993) 1543-1547
7. Murray I., Sniderman A.D., and Cianflone K. Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice. Am J Physiol 277 (1999) E474-E480
8. Bykov I., Junnikkala S., Pekna M., Lindros K.O., and Meri S. Complement C3 contributes to ethanol-induced liver steatosis in mice. Ann Med 38 (2006) 280-286
9. Kim S., Sohn I., Ahn J.I., Lee K.H., Lee Y.S., and Lee Y.S. Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene 340 (2004) 99-109
10. Recinos III A., Carr B.K., Bartos D.B., Boldogh I., Carmical J.R., Belalcazar L.M., et al. Liver gene expression associated with diet and lesion development in atherosclerosis-prone mice: induction of components of alternative complement pathway. Physiol Genomics 19 (2004) 131-142
11. Deng Q.G., She H., Cheng J.H., French S.W., Koop D.R., Xiong S., et al. Steatohepatitis induced by intragastric overfeeding in mice. Hepatology 42 (2005) 905-914
12. French B.A., Dedes J., Bardag-Gorce F., Li J., Wilson L., Fu P., et al. Microarray analysis of gene expression in the liver during the urinary ethanol cycle in rats fed ethanol intragastrically at a constant rate. Exp Mol Pathol 79 (2005) 87-94
13. Deaciuc I.V., Doherty D.E., Burikhanov R., Lee E.Y., Stromberg A.J., Peng X., et al. Large-scale gene profiling of the liver in a mouse model of chronic, intragastric ethanol infusion. J Hepatol 40 (2004) 219-227
14. Pekna M., Hietala M.A., Rosklint T., Betsholtz C., and Pekny M. Targeted disruption of the murine gene coding for the third complement component (C3). Scand J Immunol 47 (1998) 25-29
15. Bykov I., Palmen M., Piirainen L., and Lindros K.O. Oral chronic ethanol administration to rodents by agar gel diet. Alcohol Alcohol 39 (2004) 499-502
16. Jarvelainen H.A., Vakeva A., Lindros K.O., and Meri S. Activation of complement components and reduced regulator expression in alcohol-induced liver injury in the rat. Clin Immunol 105 (2002) 57-63
17. Bykov I.L., Vakeva A., Jarvelainen H.A., Meri S., and Lindros K.O. Protective function of complement against alcohol-induced rat liver damage. Int Immunopharmacol 4 (2004) 1445-1454
18. Nagao K., Inoue N., Wang Y.M., Shirouchi B., and Yanagita T. Dietary conjugated linoleic acid alleviates nonalcoholic fatty liver disease in Zucker (fa/fa) rats. J Nutr 135 (2005) 9-13
19. Tiirola T., Erkkilä L., Laitinen K., Leinonen M., Saikku P., Bloigu A., et al. Effect of acute Chlamydia pneumoniae infection on lipoprotein metabolism in NIH/S mice. Scand J Clin Lab Invest 62 (2002) 477-484
20. Jauhiainen M., Metso J., Pahlman R., Blomqvist S., van Tol A., and Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 268 (1993) 4032-4036
21. van Haperen R., van Tol A., Vermeulen P., Jauhiainen M., van Gent T., van den Berg P., et al. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol 20 (2000) 1082-1088
22. McKim S.E., Konno A., Gabele E., Uesugi T., Froh M., Sies H., et al. Cocoa extract protects against early alcohol-induced liver injury in the rat. Arch Biochem Biophys 406 (2002) 40-46
23. Siggins S., Kärkkäinen M., Tenhunen J., Metso J., Tahvanainen E., Olkkonen V.M., et al. Quantitation of the active and low-active forms of human plasma phospholipid transfer protein (PLTP) by ELISA. J Lipid Res 345 (2004) 387-395
24. Yamauchi T., Kamon J., Waki H., Imai Y., Shimozawa N., Hioki K., et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278 (2003) 2461-2468
25. Xu A., Wang Y., Keshaw H., Xu L.Y., Lam K.S., and Cooper G.J. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112 (2003) 91-100
26. Thakur V., Pritchard M.T., McMullen M.R., and Nagy L.E. Adiponectin normalizes LPS-stimulated TNF{alpha} production by rat Kupffer cells after chronic ethanol feeding. Am J Physiol Gastrointest Liver Physiol 290 (2006) G998-G1007
27. Chang B.H., Li L., Paul A., Taniguchi S., Nannegari V., Heird W.C., et al. Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein. Mol Cell Biol 26 (2006) 1063-1076
28. Horton J.D., Goldstein J.L., and Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109 (2002) 1125-1131
29. Eberlé D., Hegarty B., Bossard P., Ferré P., and Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86 (2004) 839-848
30. You M., and Crabb D.W. Molecular mechanisms of alcoholic fatty liver: role of sterol regulatory element-binding proteins. Alcohol 34 (2004) 39-43
31. Jump D.B., Botolin D., Wang Y., Xu J., Christian B., and Demeure O. Fatty acid regulation of hepatic gene transcription. J Nutr 135 (2005) 2503-2506
32. Costet P., Legendre C., More J., Edgar A., Galtier P., and Pineau T. Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J Biol Chem 273 (1998) 29577-29585
33. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103 (1999) 489-498
34. Fischer M., You M., Matsumoto M., and Crabb D.W. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J Biol Chem 278 (2003) 27997-28004
35. Asp L., Claesson C., Boren J., and Olofsson S.O. ADP-ribosylation factor 1 and its activation of phospholipase D are important for the assembly of very low density lipoproteins. J Biol Chem 275 (2000) 26285-26292
36. Calamita Z., and Burini R.C. Immunologic changes in alcoholic liver cirrhosis. Arq Gastroenterol 32 (1995) 79-84
37. Sopena B., Martinez-Vazquez C., de la Fuente J., Fernandez C., Rivera A., Rodriguez M.A., et al. Serum levels of immunoglobulins and complement in alcoholic liver disease. Rev Clin Esp 193 (1993) 419-423
38. Miner J.L., Hahn K.J., Spurlock M.E., and Staten N.R. Expression and complement D activity of porcine adipsin. Protein Expr Purif 23 (2001) 14-21